Jonathan D. Best

Statistics

Publications

Citations

1.4K

H-Index

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Jonathan D. Best is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, gamma secretase inhibition, and life sciences.

Publications per year

1999–2009

Publications

Circadian Programs of Transcriptional Activation, Signaling, and Protein Turnover Revealed by Microarray Analysis of Mammalian Cells

Giles E. Duffield, Jonathan D. Best, Bernhard H. Meurers et al. · Current Biology · 2002 · 328 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Non-Associative Learning in Larval Zebrafish

Jonathan D. Best, Stéphane Berghmans, Julia Hunt et al. · Neuropsychopharmacology · 2007 · 246 citations · Full text

Life Sciences, Biology, Neuroscience +13

Zebrafish: An in vivo model for the study of neurological diseases

Jonathan D. Best · Neuropsychiatric Disease and Treatment · 2008 · 208 citations · Full text

Life Sciences, Neurobiology, Neuroscience +10

Rapid Resetting of the Mammalian Circadian Clock

Jonathan D. Best, Elizabeth S. Maywood, Karen L. Smith et al. · Journal of Neuroscience · 1999 · 114 citations · Full text

Life Sciences, Neuroscience, Physiology +17

Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-l-alaninamide]

Jonathan D. Best, Mark T. Jay, Franklin Otu et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 98 citations

Medicine, Neuroscience, Pharmacology +14

1–5 of 12